Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 14, 2012 16:14 ET | Source: Colon Cancer Alliance

Colon Cancer Alliance Welcomes FDA's Biosimilars Guidance, Encourages Agency to Keep Patient Safety "First and Foremost"

WASHINGTON, Feb. 14, 2012 (GLOBE NEWSWIRE) -- Colon Cancer Alliance CEO Andrew Spiegel yesterday showed support for the Food and Drug Administration's (FDA) draft guidelines for an American...
February 14, 2012 14:47 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal 2012

NORTHVALE, N.J., Feb. 14, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing generic and branded oral...
February 14, 2012 09:00 ET | Source: CellaVision AB

CellaVision AB: Bokslutskommuniké 2011

Stor tillväxt i Nordamerika och förbättrad leveranskapacitet med stärkt kassaflöde 1 januari - 31 december 2011 Nettoomsättningen steg med 18 % till 155,4 MSEK (131,6) Rörelseresultatet blev 17,8...
February 14, 2012 09:00 ET | Source: CellaVision

CellaVision AB: Bokslutskommuniké 2011

Stor tillväxt i Nordamerika och förbättrad leveranskapacitet med stärkt kassaflöde 1 januari - 31 december 2011 * Nettoomsättningen steg med 18 % till 155,4 MSEK (131,6) * Rörelseresultatet blev...
February 14, 2012 09:00 ET | Source: CellaVision AB

CellaVision AB: Year-end bulletin 2011

Major growth in North America and improved delivery capacity with strengthened cash flowJanuary 1 - December 31, 2011 Net sales rose by 18 % to SEK 155.4 million (131.6) The operating result was...
February 14, 2012 08:00 ET | Source: Quick-Med Technologies, Inc.

Quick-Med Expands NIMBUS(R) Technology Into Advanced Wound Care Dressings

Viridis BioPharma Receives Approval for NIMBUS Foam Dressings from India FDA Quick-Med Licensing Partner to Manufacture and Sell NIMBUS Foam Dressings in India GAINESVILLE, Fla., Feb. 14, 2012...
February 14, 2012 07:00 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Announces Notice of Allowance for U.S. Patent Application Covering Vosaroxin Compositions

SOUTH SAN FRANCISCO, Calif, Feb. 14, 2012 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance...
February 14, 2012 06:59 ET | Source: Coronado Biosciences

Coronado Biosciences Announces IND Submission for CNDO-109 for the Treatment of Relapsed Acute Myeloid Leukemia

BURLINGTON, Mass., Feb. 14, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...
February 14, 2012 06:30 ET | Source: AngioDynamics

AngioDynamics Receives FDA Clearance for NeverTouch Direct(TM) Procedure Kit to be Used With the VenaCure EVLT(R) System

ALBANY, N.Y., Feb. 14, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
February 14, 2012 05:00 ET | Source: Bioheart Inc.

Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology

SUNRISE, Fla., Feb. 14, 2012 (GLOBE NEWSWIRE) -- Bioheart, Inc. (BHRT.OB) announced today that it has acquired the worldwide exclusive rights to Ageless Regenerative Institute's adipose (fat) derived...
February 13, 2012 16:01 ET | Source: Amicus Therapeutics, Inc.

Amicus Therapeutics Announces Fourth Quarter and Full-Year 2011 Financial Results

Phase 3 Results of Migalastat HCl Monotherapy for Fabry Disease Expected in 3Q12 Multiple Chaperone-Enzyme Replacement Therapy (ERT) Combination Programs Advancing Positive Phase 2...
February 13, 2012 09:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Granted Orphan Medicinal Product Designation in European Union for CPP-115 for the Treatment of West Syndrome (Infantile Spasms)

CORAL GABLES, Fla., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced that the European Commission (EC) has granted orphan medicinal product...
February 13, 2012 08:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Discuss Third Quarter 2012 Results of Operations on Wednesday, February 15, 2012

NORTHVALE, N.J., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
February 13, 2012 08:00 ET | Source: Amarin Corporation plc

Amarin Announces FDA Advisory Committee Will Not Be Scheduled in Connection With New Drug Application for AMR101

BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 13, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company with a focus on cardiovascular disease, announced...
February 13, 2012 08:00 ET | Source: BG Medicine, Inc.

BG Medicine Announces Positive Pivotal Validation Study Results for CardioSCORE, a New Diagnostic Blood Test to Identify Individuals at High Risk for Near-term Major Cardiovascular Events

WALTHAM, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, today announced...
February 13, 2012 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics CEO to Review NORTHERA(TM) NDA and Provide an Update on Upcoming Advisory Committee Meeting During Presentation at BIO CEO

CHARLOTTE, N.C., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that during a presentation at the 14th Annual BIO CEO and Investor Conference...
February 13, 2012 07:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Provides Update on Clinical Progress With Sapacitabine as Second Line Therapy in Older Patients With Myelodysplastic Syndromes

BERKELEY HEIGHTS, N.J., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), announced today new topline response data from an...
February 13, 2012 01:15 ET | Source: Novartis Pharma AG

FDA requests additional data on Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for expanded use in infants and toddlers

Agency issues Complete Response letter requesting more information to support approval Basel, February 13, 2012 - Novartis has received a Complete Response letter from the US Food and Drug...
February 13, 2012 01:15 ET | Source: NOVARTIS FINANCE S.A.

FDA requests additional data on Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for expanded use in infants and toddlers

Agency issues Complete Response letter requesting more information to support approval Basel, February 13, 2012 - Novartis has received a Complete Response letter from the US Food and Drug...
February 11, 2012 00:15 ET | Source: Regeneca, Inc.

Regeneca, Inc. Issues a Voluntary Nationwide Recall of a Specific Lot of RegenArouse Because of Potential Health Risks

IRVINE, Calif., Feb. 11, 2012 (GLOBE NEWSWIRE) -- Regeneca, Inc. (Pink Sheets:RGNA) announced today that it is conducting a voluntary nationwide recall of RegenArouse, Lot Number 130100, because FDA...
February 09, 2012 18:07 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Prices Registered Common Stock Offering

WIXOM, Mich., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic...
February 09, 2012 17:30 ET | Source: NeurogesX

NeurogesX Provides Update on Qutenza(R) (Capsaicin) 8% Patch for New Indication to Treat HIV-PN Following FDA Advisory Committee Review

SAN MATEO, Calif., Feb. 9, 2012 (GLOBE NEWSWIRE) -- NeurogesX (Nasdaq:NGSX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain...
February 09, 2012 16:01 ET | Source: Authentidate Holding Corp.

Authentidate Holding Corp. Reports Fiscal 2012 Second Quarter Results

BERKELEY HEIGHTS, N.J., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Authentidate Holding Corp. (Nasdaq:ADAT), a provider of secure web-based software applications and telehealth products and services for...
February 09, 2012 09:00 ET | Source: Filana Therapeutics, Inc.

Pain Therapeutics Reports 2011 Financial Results

– Balance Sheet Remains Strong – – Disciplined Spending Expected in 2012 – AUSTIN, Texas, Feb. 9, 2012 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today...
February 09, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Files U.S. Provisional Patent Application for GABA Aminotransferase Inhibitor Use in Treatment of Tourette Syndrome

CORAL GABLES, Fla., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it has filed a provisional patent application with the United States...
February 09, 2012 08:00 ET | Source: Arbutus Biopharma Corporation

Tekmira Announces USPTO Issuance of Key Patents Broadly Covering LNP Formulations and Mitigation of Immune Stimulation

VANCOUVER, B.C., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today that the...
February 09, 2012 08:00 ET | Source: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Provides Business Update and 2012 Outlook

Progress Across Four Business Units Conference Call and Webcast Today at 1:00 P.M. (ET) / 10:00 A.M. (PT) Dial-In Numbers 1-866-761-0748 (USA) or 1-617-614-2706 (International) Participant...
February 09, 2012 08:00 ET | Source: Endologix

Endologix Completes Enrollment in PEVAR Randomized Trial

IRVINE, Calif., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the completion of patient...
February 09, 2012 08:00 ET | Source: Palomar Medical Technologies, Inc.

Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2011

BURLINGTON, Mass., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Palomar Medical Technologies, Inc. (Nasdaq:PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, today announced...
February 09, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Launch of New Patient Website: NeuVax.com

Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low-to-Intermediate HER2 Expression with NeuVax Treatment) study now enrolling under an FDA approved...
February 09, 2012 07:01 ET | Source: NeurogesX

NeurogesX' Stock Trading Halted Today

SAN MATEO, Calif., Feb. 9, 2012 (GLOBE NEWSWIRE) -- NeurogesX Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management,...
February 09, 2012 02:00 ET | Source: Protalix BioTherapeutics, Inc.

Protalix Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal Disease Network Symposium

CARMIEL, Israel, Feb. 9, 2012 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE AMEX:PLX) (TASE:PLX), announced today that new clinical data on taliglucerase alfa will be presented at the 8th...
February 09, 2012 01:15 ET | Source: Basilea Pharmaceutica AG, Allschwil

Basilea reports 2011 financials with better than expected operating results

Solid cash position of CHF 197.1 million Toctino® sales of CHF 31 million representing a 24 percent year-on-year volume growth Significant progress in its development pipeline potentially...
February 09, 2012 01:15 ET | Source: Basilea Pharmaceutica AG, Allschwil

Basilea veröffentlicht Finanzbericht für das Geschäftsjahr 2011 mit einem besser als erwarteten operativen Ergebnis

Solide Liquiditätsausstattung in Höhe von CHF 197.1 Mio. Produktumsätze mit Toctino® in Höhe von CHF 31 Mio., entsprechend einem Volumenwachstum um 24 Prozent im Jahresvergleich Signifikante...
February 08, 2012 16:00 ET | Source: OraSure Technologies, Inc.

OraSure Announces Fourth Quarter and Full-Year 2011 Financial Results

BETHLEHEM, Pa., Feb. 8, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), a market leader in oral fluid diagnostics, today announced its consolidated financial results for the fourth...
February 08, 2012 14:35 ET | Source: Aeolus Pharmaceuticals

Aeolus' AEOL 10150 Protects Lung Tissue From Radiation by Modulating PTEN Levels, Reducing Oxidative Stress and Apoptosis

MISSION VIEJO, CA--(Marketwire - Feb 8, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS) Data published in the International Journal of Radiation...
February 08, 2012 14:32 ET | Source: Pomerantz LLP

Pomerantz Law Firm Reminds Shareholders of Columbia Laboratories, Inc. of Upcoming Deadline -- CBRX

NEW YORK, Feb. 8, 2012 (GLOBE NEWSWIRE) -- Shareholders of Columbia Laboratories, Inc. ("Columbia" or the "Company") (Nasdaq:CBRX) are reminded of the securities class action lawsuit filed against...
February 08, 2012 12:55 ET | Source: Octopus Titan VCT plc

Octopus Titan VCT 2 PLC : Final Results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Octopus Titan VCT 2 plc Final Results 8 February...
February 08, 2012 11:38 ET | Source: Southeastern Medical Device Association

FDA Deputy Director for Medical Devices to Speak at SEMDA 2012 Conference

ATLANTA, GA--(Marketwire - Feb 8, 2012) - William H. Maisel, MD, MPH, Chief Scientist and Deputy Center Director for Science at the U.S. Food and Drug Administration's (FDA) Center for Devices and...
February 08, 2012 09:30 ET | Source: Pivotal Therapeutics Inc.

Taglich Brothers Initiates Coverage on Pivotal Therapeutics Inc.

NEW YORK, NY--(Marketwire - Feb 8, 2012) - Taglich Brothers, Inc. announces it initiated coverage of Pivotal Therapeutics Inc. Pivotal Therapeutics Inc. (CNSX: PVO) headquartered in...
February 08, 2012 09:15 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces 2011 Year End Results

TORONTO, Feb. 8, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
February 08, 2012 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. to Present at 2012 BIO CEO Investor Conference

NEWARK, Calif., Feb. 8, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will present an update on the Company's programs and operations at...
February 08, 2012 08:00 ET | Source: Arbutus Biopharma Corporation

Tekmira Announces Initiation of TKM-Ebola Phase 1 Clinical Trial

VANCOUVER, British Columbia, Feb. 8, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced...
February 08, 2012 08:00 ET | Source: Computer Vision Systems Laboratories Corp.

Computer Vision Systems Laboratories Corp. Announces the Appointments of Dr. Charles Mandell and Dr. Richard Lynch to Its Scientific Advisory Board

BOCA RATON, Fla., Feb. 8, 2012 (GLOBE NEWSWIRE) -- Computer Vision Systems Laboratories Corp. (CVSL.OB OTCBB) , announced today that it has appointed two new members to its Scientific Advisory...
February 08, 2012 07:00 ET | Source: Theratechnologies inc.

Theratechnologies annonce ses résultats de l'exercice 2011

MONTRÉAL, CANADA--(Marketwire - 8 fév. 2012) - Theratechnologies inc. (Theratechnologies) (TSX:TH)(NASDAQ:THER) a annoncé aujourd'hui ses résultats financiers de...
February 08, 2012 07:00 ET | Source: Theratechnologies Inc.

Theratechnologies Announces Results for Fiscal Year 2011

MONTREAL, CANADA--(Marketwire - Feb. 8, 2012) - Theratechnologies Inc. (Theratechnologies) (TSX:TH)(NASDAQ:THER) today announced its financial results for the fiscal year ended November...
February 08, 2012 07:00 ET | Source: Curis, Inc.

Curis Reports Fourth Quarter and Year-End 2011 Financial Results

LEXINGTON, Mass., Feb. 8, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer...
February 08, 2012 06:30 ET | Source: AngioDynamics

AngioDynamics Launches DuraFlow(TM) 2 Chronic Hemodialysis Catheter

ALBANY, N.Y., Feb. 8, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
February 08, 2012 06:30 ET | Source: Vical Incorporated

Vical Reports 2011 Financial Results and Progress in Key Development Programs

SAN DIEGO, Feb. 8, 2012 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the year ended December 31, 2011. Vical had cash and investments of approximately $56...
February 08, 2012 01:30 ET | Source: GENFIT S.A.

GENFIT: CONCLUSIVE RESULTS OF REGULATORY TOXICOLOGY STUDIES WITH GFT505

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} CONCLUSIVE RESULTS OF REGULATORY TOXICOLOGY...